Weight loss has never been more accessible than now, as we enter 2025. This year could well be the year you no longer have to step on the scales with a pit in your stomach. That’s because, due to huge strides in scientific research and clinical trials, this is the era where effective and sustainable weight loss solutions are widely available.
From evidence-based techniques to practical advice, the nurse-led medical weight loss team at Bodyline have put together the tips they offer our clients to ensure they stick to their goals. Weight loss doesn’t have to be a failed New Year’s resolution anymore, and with the help of supported medical weight health management programmes at Bodyline, your goals are no longer out of reach!
Whether you’re about to embark on a transformative weight loss journey, or are in the middle of one, the run up to Christmas in December is always a challenge.
From the booked-up calendar of food or alcohol-based events to the stress of organization and the big day itself, it can sometimes feel virtually impossible to stay on track. That’s especially the case when you are working towards long term goals and trying change the relationship you have with food.
Psoriasis is a chronic autoimmune condition that affects the skin, causing itchy and painful patches of red, scaly skin. It can be a debilitating condition, with many patients struggling to find effective treatments. However, low dose naltrexone (LDN) has shown promising results as a potential treatment for psoriasis.
Crohn’s disease is a chronic inflammatory bowel disease that affects millions of people worldwide. It causes inflammation in the digestive tract, leading to symptoms like abdominal pain, diarrhoea, and weight loss. While there are various treatment options available for Crohn’s disease, including medications, surgery, and lifestyle changes, these options often come with unwanted side effects and are not always effective, and some sufferers must resort to using a life changing colostomy bag.
Low Dose Naltrexone (LDN) is a medication that has been found to be effective in treating various medical conditions, including autoimmune diseases, chronic pain, and reported to have promising results for people with primary cancer. Despite its proven efficacy, LDN is not a licensed medicine in the UK, which makes it challenging to obtain. Fortunately, Bodyline offers a private prescription service for LDN that can help you access this medication.
When opting for holistic, high-quality healthcare, it’s important to learn as much as you can about the latest tools and equipment that can help offer the very best diagnosis and treatments.
That’s why we’ve chosen to use the Tap II Blood Collection Device as part of many of our EXPLORE diagnostic wellness treatment solutions, so that we can take blood samples as easily as possible, without the need for appointments, waiting rooms, or scheduling.
But what is the TAP® II Blood Collection Device, and how does it work?
Low Dose Naltrexone (LDN) is a medication that is gaining popularity in the medical community as a promising treatment option for a variety of conditions such as chronic pain, autoimmune diseases, and Crohn’s disease.
Naltrexone has been used for decades to treat opioid addiction and alcoholism. It works by blocking the receptors in the brain that are responsible for the effects of these substances. When used in low doses, naltrexone has been found to have a completely different effect on the body.
It’s disappointing but no longer surprising that once again medical weight loss injections are being misused, so much so that the UK’s drug safety regulator is asking doctors to be alert for patients who may be misusing obesity injections, such as Wegovy.
In November 2024, the National Institute for Health and Care Excellence (Nice) released guidance that women with menopausal symptoms should be offered hormone replacement therapy (HRT) as the initial treatment as opposed to therapy.
The Bodyline team were incredibly saddened to hear about the passing of Susan McGown, following the news that her tragic death was reported to be linked to being prescribed Mounjaro.
Here at our clinics, we have supportive relationships with all of our patients, and have felt the anxiety and reactions to this terrible news. However, we also want to ease the minds of those patients and those looking to begin a supported medical weight loss journey.
